Last reviewed · How we verify
NCT03625609
Sexaffectivity in Autistic Spectrum Disorder
trial in Autistic Disorders Spectrum in 200 participants. Status unknown.
11 February 2020
Quick facts
| Lead sponsor | Parc Taulí Hospital Universitari |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 11 March 2018 |
| Primary completion | 11 February 2020 |
| Estimated completion | 11 July 2020 |
| Sites | 1 location across Spain |
Conditions studied
- Autistic Disorders Spectrum — all drugs for Autistic Disorders Spectrum →
- Sexual Behavior — all drugs for Sexual Behavior →
- Adolescent Development — all drugs for Adolescent Development →
- Sexual Inadequacy — all drugs for Sexual Inadequacy →
Sponsor
Parc Taulí Hospital Universitari
Who can join
Adults 12 to 18, any sex, with Autistic Disorders Spectrum or Sexual Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The WHO defines sexual health as a state of physical, emotional, mental and social well-being, related to sexuality, not only the absence of illness, dysfunction or disability. To acquire and maintain adequate sexual health, the sexual rights of all people must be respected, protected and fully exercised. People with Autism Spectrum Disorder (ASD) present difficulties in the development of social interaction skills, among other problems that directly affect their sexual health. The consolidated prejudices and social myths related to the sexual affectivity of people with ASD, and in general to people with intellectual diversity, have meant that they do not pay any attention to the sexual health of this group in the assessment of their needs. Main objectives: to understand the experience lived by young people with ASD and their caregivers in relation to the affective needs during adolescence and to know the cognitive and behavioral expression of the affective dimension of adolescents with ASD. Mixed simultaneous design: qualitative based on the phenomenological paradigm, in order to establish the perceived needs of young adults with ASD, their families and the professionals who attend them, with the realization of focus groups and in-depth interviews. The second quantitative part will be developed in adolescents (12-18 years) and their families, evaluating the habitual behaviors and difficulties of Interaction in the affective expression, by means of questionnaires and self-administered scales. It will be necessary to sign the Informed Consent by all the participants, with the specific acceptance of the project by the CEIC of the investigator's center.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03625609
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Autistic Disorders Spectrum
Currently open trials in the same condition.
- NCT05910502 — Project AFECT (Autism Family Empowerment Coaching and Training Program) · NA · active not recruiting
- NCT05035511 — A Machine Learning Approach for Predicting tDCS Treatment Outcomes of Adolescents With Autism Spectrum Disorders · NA · recruiting
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other Parc Taulí Hospital Universitari trials
Trials by the same sponsor.
- NCT06341374 — Impact of Sleep Disorders on Innate Immunity in COVID-19 Patients · unknown
- NCT06551636 — Effects on the Expiratory Flow of AAD in a Critical Patient With IMV · completed
- NCT05032794 — Unrestricted Diet for Screening Colonoscopy · NA · completed
- NCT04664543 — Efficacy of Free Versus Low Residue Diet as Preparation for Screening Colonoscopy · NA · terminated
- NCT03763266 — Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03625609 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Parc Taulí Hospital Universitari
- Last refreshed: 10 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03625609.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing